Expand links In this section

Rabbit Haemorrhagic Disease Virus (Calicivirus)

In May 2015, a rabbit in Canberra was found to be infected with a new strain of rabbit haemorrhagic disease virus (Calicivirus), known as RHDV2. This new virus strain was first reported in France in 2010 and has been found in several other European countries. It is not known how it entered Australia.

This new virus strain is distinct from RHDV1, the strain released in Australia in 1996 for the control of wild rabbits. Since the effectiveness of the RHDV1 strain as a biocontrol agent has decreased with time, a new naturally occurring variant of RHDV1 (called K5) is proposed for release, pending approvals. This intends to boost the effectiveness of the current RHDV1 strain.

Vaccination

Protection against RHDV2

The calicivirus vaccine currently used in Australia (for RHDV1) may only provide partial protection against the RHDV2 strain.  However, if a more rigorous vaccination programme is used, this may assist in protecting against RHDV2.

Protection against RHDV1 (K5)

A NSW Department of Primary Industries pilot study (through the Invasive Animals CRC) assessed the current calicivirus vaccine for its effectiveness in protecting domestic and production rabbits from K5. Results of this study indicated that the currently registered vaccine is effective against K5 if correct vaccination protocols are followed.

Recommendations for vaccinating rabbits against all strains of calicivirus are available on the Australian Veterinary Association website.

Last reviewed:
10 Dec 2015